HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melchor Alvarez-Mon Selected Research

Immunoferon (AM3)

7/2010The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis.
5/2008[Effect of AM3 on health-related quality of life in patients with chronic obstructive pulmonary disease belonging to risk groups].
3/2006Treatment with AM3 restores defective T-cell function in COPD patients.
4/2005Treatment with the immunomodulator AM3 improves the health-related quality of life of patients with COPD.
5/2002AM3 (Inmunoferón) as an adjuvant to hepatitis B vaccination in hemodialysis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Melchor Alvarez-Mon Research Topics

Disease

6Infections
12/2017 - 05/2002
5Neoplasms (Cancer)
05/2022 - 10/2004
5Fibrosis (Cirrhosis)
07/2010 - 01/2003
4Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 11/2021
4Dengue (Dengue Fever)
12/2017 - 03/2014
3Major Depressive Disorder (Major Depressive Disorders)
05/2022 - 03/2021
3Inflammation (Inflammations)
01/2019 - 08/2005
3Chronic Obstructive Pulmonary Disease (COPD)
05/2008 - 04/2005
2Crohn Disease (Crohn's Disease)
03/2022 - 05/2006
2Rheumatoid Arthritis
01/2015 - 07/2012
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2014 - 07/2013
2Asthma (Bronchial Asthma)
01/2014 - 04/2013
2Sepsis (Septicemia)
01/2014 - 06/2012
2Necrosis
07/2010 - 04/2004
2Bacterial Infections (Bacterial Infection)
08/2005 - 05/2004
2Lymphoma (Lymphomas)
03/2005 - 03/2005
2Ascites
05/2004 - 01/2003
1Cardiovascular Diseases (Cardiovascular Disease)
11/2022
1Severe Acute Respiratory Syndrome
06/2022
1Autoimmune Diseases (Autoimmune Disease)
06/2022
1Abdominal Aortic Aneurysm
04/2022
1Adenocarcinoma
01/2022
1Body Weight (Weight, Body)
12/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2021
1Colitis
12/2021
1Obesity
10/2021
1Birth Weight (Birth Weights)
07/2021
1Hypoxia (Hypoxemia)
06/2021
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
06/2021
1Spinal Cord Injuries (Spinal Cord Injury)
01/2021
1Infertility (Sterility)
01/2021
1Viremia
10/2016
1Immediate Hypersensitivity
10/2015
1Uterine Cervical Dysplasia
04/2015
1Hypersensitivity (Allergy)
01/2015
1Drug Fever
01/2015
1Urticaria (Hives)
01/2015
1Virus Diseases (Viral Diseases)
03/2014
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2012
1Septic Shock (Toxic Shock Syndrome)
03/2011

Drug/Important Bio-Agent (IBA)

14CytokinesIBA
06/2022 - 01/2003
8Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2014
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2021 - 04/2004
5Immunoferon (AM3)IBA
07/2010 - 05/2002
4Immunologic Factors (Immunomodulators)IBA
07/2010 - 04/2005
3LigandsIBA
09/2015 - 10/2004
3Interleukin-6 (Interleukin 6)IBA
03/2014 - 05/2006
3Biological ProductsIBA
01/2014 - 07/2012
3InterleukinsIBA
03/2011 - 03/2005
3Interleukin-2 (IL2)IBA
07/2010 - 05/2006
2VaccinesIBA
06/2022 - 05/2002
2Interleukin-12 (IL 12)IBA
06/2022 - 03/2014
2Malondialdehyde (Propanedial)IBA
05/2022 - 06/2021
2Caspase 3 (Caspase-3)IBA
12/2021 - 03/2005
2Proteins (Proteins, Gene)FDA Link
12/2021 - 10/2015
2Interleukin-17 (Interleukin 17)IBA
03/2021 - 03/2014
2NucleotidesIBA
12/2017 - 03/2014
2InterferonsIBA
10/2016 - 10/2002
2Cytokine Receptors (Cytokine Receptor)IBA
09/2015 - 03/2014
2Interleukin-10 (Interleukin 10)IBA
07/2010 - 05/2006
2Interferon-gamma (Interferon, gamma)IBA
07/2010 - 08/2005
2Etoposide (VP 16)FDA LinkGeneric
03/2005 - 03/2005
2Hydroxyurea (Hydrea)FDA LinkGeneric
03/2005 - 03/2005
1SugarsIBA
05/2022
1Antidepressive Agents (Antidepressants)IBA
01/2022
1Cyclin D1IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
12/2021
1AlbuminsIBA
12/2021
1Caspase 8 (Caspase-8)IBA
12/2021
1Cyclin EIBA
12/2021
1Insulin-Like Growth Factor I (IGF-1)IBA
12/2021
1Anti-Obesity Agents (Antiobesity Drugs)IBA
10/2021
1ErbB Receptors (EGF Receptor)IBA
12/2017
1prolinedithiocarbamate (PDTC)IBA
12/2017
1NF-kappa B (NF-kB)IBA
12/2017
1Interleukin-8 (Interleukin 8)IBA
04/2015
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
04/2015
1ChemokinesIBA
04/2015
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
04/2015
1Methotrexate (Mexate)FDA LinkGeneric
01/2015
1Pharmaceutical PreparationsIBA
01/2015
1Bendamustine HydrochlorideFDA Link
01/2015
1Interleukin-1 (Interleukin 1)IBA
03/2014
1Interleukin-1 Receptor-Like 1 ProteinIBA
03/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
03/2014
1TNF-Related Apoptosis-Inducing LigandIBA
03/2014
1Chemokine ReceptorsIBA
01/2014
1Mannitol (Osmitrol)FDA LinkGeneric
04/2013
1Adalimumab (Humira)FDA Link
07/2012
1Transforming Growth Factors (Transforming Growth Factor)IBA
06/2012
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
03/2011

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2021 - 06/2021
1Mediterranean Diet
11/2022
1Prostheses and Implants (Prosthesis)
04/2022
1Immunotherapy
11/2021
1Radiotherapy
11/2021
1Induced Labor
07/2021
1Surgical Instruments (Clip)
07/2021
1Episiotomy
07/2021
1Contraception (Birth Control)
01/2021